Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMENUTS Trial
NCT07721610Phase 4Completed
- Sponsor
- Gemelli Isola Hospital
- Start
- Oct 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in otitis media with effusion (OME) (3 arms), sponsored by Gemelli Isola Hospital. Primary endpoints: Tympanometric resolution at 3 weeks and Audiometric improvement at 3 weeks. Started Oct 2025; status: completed.
02
Conditions
otitis media with effusion (OME)
Beyond the preview
Go deeper on NCT07721610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07721610.